Heartflow FFRCT trial data show 44% drop in unnecessary invasive heart catheterizations

PUBT · 2d ago
Heartflow FFRCT trial data show 44% drop in unnecessary invasive heart catheterizations
  • Heartflow announced one-year results from the government-funded FUSION randomized trial, already presented at ESC Congress 2026.
  • Adding its non-invasive FFRCT analysis to standard CCTA reduced unnecessary invasive heart catheterization procedures versus CCTA alone.
  • Revascularization rates were unchanged, supporting that fewer diagnostic procedures did not reduce access to needed interventions.
  • Safety outcomes were comparable between pathways, strengthening the case for broader clinical adoption at a key referral decision point.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Heartflow Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608280248OMX_____CNEWS_EN_GNW9817571_en) on August 28, 2026, and is solely responsible for the information contained therein.